These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


214 related items for PubMed ID: 18058663

  • 1. [Nephrogenic systemic fibrosis--a new interdisciplinary challenge].
    Witzke O, Hillen U, Barkhausen J, Daul A, Kribben A.
    Dtsch Med Wochenschr; 2007 Dec; 132(50):2706-10. PubMed ID: 18058663
    [Abstract] [Full Text] [Related]

  • 2. [Nephrogenic systemic fibrosis].
    Samtleben W.
    Radiologe; 2007 Sep; 47(9):778-84. PubMed ID: 17717643
    [Abstract] [Full Text] [Related]

  • 3. [Nephrogenic systemic fibrosis as an adverse drug reaction of gadolinium-based contrast media for magnetic resonance imaging].
    Giersig C.
    Radiologe; 2007 Sep; 47(9):794-9. PubMed ID: 17713753
    [Abstract] [Full Text] [Related]

  • 4. Nephrogenic systemic fibrosis: is gadolinium the missing piece to the puzzle?
    Bennett LK, Garrett AL.
    Cutis; 2008 May; 81(5):421-6. PubMed ID: 18543594
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Nephrogenic fibrosing dermopathy treated with extracorporeal photopheresis: role of gadolinium?].
    Kintossou R, D'Incan M, Chauveau D, Bens G, Franck F, Dauplat MM, Viraben R, Déchelotte P, Souteyrand P.
    Ann Dermatol Venereol; 2007 May; 134(8-9):667-71. PubMed ID: 17925692
    [Abstract] [Full Text] [Related]

  • 8. Nephrogenic systemic fibrosis: a serious iatrogenic disease of renal failure patients.
    Khurram M, Skov L, Rossen K, Thomsen HS, Marckmann P.
    Scand J Urol Nephrol; 2007 May; 41(6):565-6. PubMed ID: 17934986
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Gadolinium-enhanced magnetic resonance imaging, renal failure and nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy.
    Stratta P, Canavese C, Aime S.
    Curr Med Chem; 2008 May; 15(12):1229-35. PubMed ID: 18473815
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nephrogenic systemic fibrosis: a review and exploration of the role of gadolinium.
    Cowper SE.
    Adv Dermatol; 2007 May; 23():131-54. PubMed ID: 18159899
    [Abstract] [Full Text] [Related]

  • 17. Gadolinium and nephrogenic systemic fibrosis: association or causation.
    Kurtkoti J, Snow T, Hiremagalur B.
    Nephrology (Carlton); 2008 Jun; 13(3):235-41. PubMed ID: 18221255
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Are patients with moderate renal failure at risk for developing nephrogenic systemic fibrosis?
    Saab G, Abu-Alfa A.
    Radiology; 2007 Sep; 244(3):930-1; author reply 931-2. PubMed ID: 17709844
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.